Perion Network Ltd. has reported its financial results for the third quarter of 2026, revealing a substantial revenue decline of 18% compared to the same period last year. This decline comes as the company prepares for a merger with Affle 3IL Ltd., an all-cash transaction valued at approximately $420 million. The merger is expected to close in early 2027, pending shareholder approval and other closing conditions.
The results indicate that Perion is facing challenges in its core advertising solutions segment, which accounted for 77% of its revenue. The company has also suspended its share repurchase program due to the pending merger, signaling a shift in focus towards the transaction with Affle.
Background
Perion Network Ltd., listed on Nasdaq under the ticker PERI, operates in the computer programming services sector (SIC: 7371). The company specializes in digital advertising technologies, leveraging AI to optimize advertising outcomes. Recent filings show a series of 6-K submissions, with the latest on November 16, 2026, detailing its financial performance and merger activities.
What the Filing Says
According to the filing dated November 16, 2026, Perion reported a total revenue of $90.8 million for the third quarter, down from $110.5 million in the same quarter of 2025. The company also noted a GAAP net loss of $9.9 million, compared to a loss of $4.1 million a year earlier. The filing stated, "In light of the pending transaction, Perion will not host an earnings conference call. Additionally, Perion has withdrawn all previously issued financial outlook and targets." This indicates a cautious approach as the company navigates the merger process.
Impact
The merger with Affle is likely to impact Perion's operations significantly, as it will become a wholly-owned subsidiary of Affle upon completion. The transaction includes a 40-day "go-shop" period, allowing Perion to seek alternative acquisition proposals, which could influence its strategic direction. The results and merger plans may also affect stakeholders, including shareholders and employees, as the company reassesses its financial outlook and operational strategies.
What's Next
The filing does not say what happens next, but the ongoing "go-shop" process will conclude on December 11, 2026, after which Perion will need to finalize its assessment regarding the merger and any potential impairment charges related to its goodwill.
Read Next
Cadiz Inc. reports Q3 results, shows $7.07 million loss
Ascentage Pharma's Drugs Included in China's Reimbursement List
IGI CEO to Present at Southwest IDEAS Investor Conference
Unicycive Therapeutics announces third-quarter results
FF EAI Robotics Ecosystem reports Q3 results amid challenges
Wetouch Technology Inc. Reports Q3 2026 Financial Results






